The Effect of Sumatriptan and Placebo on CGRP Induced Headache
Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
To develop a pragmatic migraine model the investigators will induce headache in healthy
volunteers and in patients with migraine without aura with aCalcitonine Gene Related Peptide
(CGRP). If the headache responds to sumatriptan, the model can be used to test new drug
candidates.